Dr Reddy’s announced its entry into the Colombian Market
In a filing to the exchanges on 7th October 2016, Dr Reddy’s Laboratories announced its entry into the Colombian market with its cancer drugs portfolio.
MV Ramana, the Executive Vice President and Head Branded Markets-Global Generics of Dr Reddy’s Laboratories said in the regulatory filing said that the company has a track record of staying commited to the markets we serve and it is delighted to make a beginning towards serving the unmet needs of patients in Colombia.
The Hyderabad-based firm operates in all major markets across the globe including the US, Russia, CIS countries as well as Europe with a workforce of above 20,000 employees approximately.
Currently, Dr Reddy’s is the second largest generic oncology injectable company by value in the US and leading generic oncology firm in India.
At present Dr Reddys share price is currently trading at Rs 3,084.00, up by 0.97 per cent or 29.70 points. A total of 1,44,149 shares of the company have been traded on the counter of NSE amounting to a total amount of Rs 4,427.98 lacs. The intraday high and the intraday low of the share today are Rs 3,085.50 and Rs 3,039.00 respectively.
The Lower Price Band of the share is 2,748.90 and the Upper Price Band is 3,359.70. The 52 week high of Dr Reddys share price is Rs 4,386.60 touched on 20th October 2015 and the 52 week low is Rs 2,750.05 made on 21st January 2016. The 52 week high of the share is its lifetime high too. The lifetime low is Rs 38.01 made on 10th December 1996. The marker cap of the company as of today is Rs 50613.05 cr.
Dr Reddys is one of the Top 500 shares of Dynamic Levels. Get the important support and resistance levels of the share at Dr Reddys share price forecast.